Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Alnylam Announces Positive Initial Phase 1b Data for Brezosiran (ALN-HTT02) Demonstrating Deep and Durable Huntingtin Lowering in Huntington’s Disease

businesswire.com
ALNY

Georgiamune und die Menarini Group schließen eine exklusive weltweite Lizenz- und Kooperationsvereinbarung für GIM-621, ein First-in-Class-Präparat für die orale Immunonkologie

prnewswire.com
STEM

SUNMI bringt eine Produktfamilie mit Windows-Betriebssystem für den gewerblichen Einsatz auf den Markt und erweitert damit die Auswahl an Computerlösungen für den intelligenten Handel

prnewswire.com
INTC

Sigma FP2 Mirrorless Camera Evolves the Compact, Hybrid, Full-Frame Formula, Announced; YouTube First Look Video and More Info at B&H

globenewswire.com
BHF SGLY

Telefónica and IQM to Provide the Community of Madrid With Its First Quantum Computer to Drive the Development of Industry Use Cases Across the Region

businesswire.com
IQMX

Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer

globenewswire.com
BMY

Form 8.3

businesswire.com
PLD

2026 CSCCP-ASCCP Colposcopy Training Course--Wuhan Station Concludes, Promoting More Precise and Non-Invasive Management of Cervical Lesions

prnewswire.com
ASST

From Small Clinical Trials to a Single Patient, Genialis Demonstrates the Power of Biology-First AI in Cancer Research

businesswire.com
GTLB

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

globenewswire.com
EVAX
View all news →